Bone marrow transplants from peripheral blood.
作者信息
Holyoake T L, Franklin I M
出版信息
BMJ. 1994 Jul 2;309(6946):4-5. doi: 10.1136/bmj.309.6946.4.
Abstract
摘要
相似文献
1
Bone marrow transplants from peripheral blood.外周血造血干细胞移植。
BMJ. 1994 Jul 2;309(6946):4-5. doi: 10.1136/bmj.309.6946.4.
2
3
Blood and marrow transplantation activity in Europe 1997. European Group for Blood and Marrow Transplantation (EBMT).1997年欧洲血液与骨髓移植活动。欧洲血液与骨髓移植组（EBMT）
Bone Marrow Transplant. 1999 Aug;24(3):231-45. doi: 10.1038/sj.bmt.1701866.
4
Blood and marrow transplantation activity in Europe 1996. European Group for Blood and Marrow Transplantation (EBMT).1996年欧洲的血液和骨髓移植活动。欧洲血液和骨髓移植组（EBMT）。
Bone Marrow Transplant. 1998 Aug;22(3):227-40. doi: 10.1038/sj.bmt.1701329.
5
Comparison of haematological recovery times and supportive care requirements of autologous recovery phase peripheral blood stem cell transplants, autologous bone marrow transplants and allogeneic bone marrow transplants.自体恢复期外周血干细胞移植、自体骨髓移植和异基因骨髓移植的血液学恢复时间及支持性护理需求比较。
Bone Marrow Transplant. 1992 Apr;9(4):277-84.
6
Hematopoietic stem cell transplantation activity in Europe 1999.1999年欧洲造血干细胞移植活动
Bone Marrow Transplant. 2001 May;27(9):899-916. doi: 10.1038/sj.bmt.1702995.
7
Autologous bone marrow transplants to hematopoietic stem cell support with peripheral blood stem cells: a historical perspective.采用外周血干细胞进行造血干细胞支持的自体骨髓移植：历史视角
J Hematother. 1999 Jun;8(3):233-6. doi: 10.1089/106161299320244.
8
Blood and marrow transplantation activity in Europe 1995. European Group for Blood and Marrow Transplantation (EBMT).1995年欧洲的血液与骨髓移植活动。欧洲血液与骨髓移植组（EBMT）
Bone Marrow Transplant. 1997 Mar;19(5):407-19. doi: 10.1038/sj.bmt.1700694.
9
Cryopreservation of hematopoietic stem/progenitor cells for therapeutic use.用于治疗的造血干/祖细胞的冷冻保存。
Methods Mol Biol. 2007;368:237-59. doi: 10.1007/978-1-59745-362-2_17.
10
Cost analysis of autologous peripheral stem cell transplantation versus autologous bone marrow transplantation for patients with non Hodgkin's lymphoma and acute lymphoblastic leukaemia.非霍奇金淋巴瘤和急性淋巴细胞白血病患者自体外周血干细胞移植与自体骨髓移植的成本分析
Leuk Lymphoma. 1999 Dec;36(1-2):33-43. doi: 10.3109/10428199909145947.
引用本文的文献
1
Haemopoietic growth factors.造血生长因子
Postgrad Med J. 1997 Apr;73(858):215-21. doi: 10.1136/pgmj.73.858.215.
2
Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer.表柔比星、紫杉醇和非格司亭治疗后转移性乳腺癌患者循环祖细胞的收集
Br J Cancer. 1997;75(9):1368-72. doi: 10.1038/bjc.1997.231.
3
Autografts of peripheral blood stem cells.外周血干细胞自体移植。
BMJ. 1994 Aug 6;309(6951):411-2. doi: 10.1136/bmj.309.6951.411b.
4
Contamination of bone marrow transplants from peripheral blood.外周血来源的骨髓移植污染
BMJ. 1994 Oct 8;309(6959):958. doi: 10.1136/bmj.309.6959.958a.
5
Bone marrow transplants from peripheral blood.外周血造血干细胞移植。
BMJ. 1994 Sep 10;309(6955):671. doi: 10.1136/bmj.309.6955.671a.
6
Bone marrow transplantation. Comparative data on quality of care and outcome are urgently needed.骨髓移植。迫切需要有关护理质量和结果的对比数据。
BMJ. 1995 Apr 1;310(6983):874-5. doi: 10.1136/bmj.310.6983.874b.
本文引用的文献
1
Myelosuppression and "conventional" chemotherapy: what price, what benefit?骨髓抑制与“传统”化疗：代价几何，益处何在？
J Clin Oncol. 1993 Jan;11(1):1-2. doi: 10.1200/JCO.1993.11.1.1.
2
Bone marrow transplantation.骨髓移植
N Engl J Med. 1994 Mar 24;330(12):827-38. doi: 10.1056/NEJM199403243301206.
3
Use of peripheral-blood progenitor cells abrogates the myelotoxicity of repetitive outpatient high-dose carboplatin and cyclophosphamide chemotherapy.使用外周血祖细胞可消除门诊重复高剂量卡铂和环磷酰胺化疗的骨髓毒性。
J Clin Oncol. 1993 Aug;11(8):1583-91. doi: 10.1200/JCO.1993.11.8.1583.
4
Peripheral blood stem cell transplantations: past, present and future.外周血干细胞移植：过去、现在与未来。
Stem Cells. 1993 May;11(3):154-72. doi: 10.1002/stem.5530110302.
5
Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation.外周血干细胞作为异基因移植中骨髓的替代物。
Lancet. 1993 Jun 5;341(8858):1482. doi: 10.1016/0140-6736(93)90929-b.
6
Treatment of severe combined immunodeficiency disease (SCID) due to adenosine deaminase deficiency with CD34+ selected autologous peripheral blood cells transduced with a human ADA gene. Amendment to clinical research project, Project 90-C-195, January 10, 1992.用转导人腺苷脱氨酶（ADA）基因的CD34 +选择自体外周血细胞治疗腺苷脱氨酶缺乏所致重症联合免疫缺陷病（SCID）。1992年1月10日对临床研究项目90 - C - 195的修正。
Hum Gene Ther. 1993 Aug;4(4):521-7. doi: 10.1089/hum.1993.4.4-521.
7
Retroviral-mediated gene transfer into CD34-enriched human peripheral blood stem cells.逆转录病毒介导的基因转移至富含CD34的人外周血干细胞中。
Exp Hematol. 1993 Apr;21(4):585-91.
8
9
10
High levels of circulating haemopoietic stem cells in very early remission from acute non-lymphoblastic leukaemia and their collection and cryopreservation.急性非淋巴细胞白血病极早期缓解时循环造血干细胞的高水平及其采集与冷冻保存
Br J Haematol. 1984 Nov;58(3):399-410. doi: 10.1111/j.1365-2141.1984.tb03987.x.
Zotero 插件